Genicular Artery Embolization in Sarasota & Bradenton
Knee Pain from Arthritis, Treated Without Surgery. A New Option for Patients Who Aren’t Ready for Replacement.
Genicular artery embolization โ known as GAE โ is a minimally invasive catheter-based procedure that reduces chronic knee pain caused by osteoarthritis. By delivering tiny microspheres to the arteries that supply the inflamed synovial lining of the knee, GAE reduces blood flow to the area of inflammation and relieves pain โ without surgery, without implants, and without a hospital stay.
GAE is an emerging option for patients with mild to moderate knee osteoarthritis who have knee pain that has not responded adequately to conservative measures and who are not ready or not appropriate candidates for knee replacement surgery. Vascular Wellness Institute offers GAE as part of our commitment to expanding non-surgical treatment options for patients in Sarasota and Bradenton.
How GAE Works
In osteoarthritis, the inflamed synovium โ the tissue lining the knee joint โ develops an abnormally dense network of tiny blood vessels that contribute to pain and inflammation. GAE targets these vessels. A catheter is inserted through a small puncture in the wrist or groin and guided under X-ray to the genicular arteries supplying the knee. Tiny microspheres โ smaller than a grain of sand โ are delivered to reduce blood flow in the inflamed synovium. This decreases the inflammatory signals driving pain without affecting the bone, cartilage, or joint structure.
What the Evidence Shows
GAE has been studied in multiple prospective case series, sham-controlled trials, and multicenter studies. Early evidence โ including prospective work by Okuno and colleagues and subsequent research โ showed meaningful reductions in pain scores at six to twelve months. A 2024 randomized sham-controlled trial and a 2026 Society of Interventional Radiology position statement both support GAE as a reasonable option for selected patients, while noting that long-term durability data and optimal patient selection criteria are still evolving. The procedure does not treat the underlying structural joint disease but can provide meaningful functional pain relief. It is important to understand that the evidence base for GAE is still developing, and this should be part of your informed discussion with your physician before proceeding.
GAE uses embolic microspheres that are FDA-approved or FDA-cleared devices; however, their use specifically for knee osteoarthritis pain relief is an off-label application in the United States. This means the procedure is performed using approved devices for a purpose described in peer-reviewed literature but not yet carrying a dedicated FDA indication for this use. Your physician will discuss the off-label nature of this application, the current state of the evidence, and what it means for your care during your consultation.
Who Is a Candidate?
- Adults with confirmed knee osteoarthritis on X-ray or MRI
- Chronic knee pain (typically three months or longer)
- Inadequate relief from conservative treatments (physical therapy, injections, NSAIDs)
- Not yet ready for or not appropriate for total knee replacement
- No contraindications to contrast dye or catheter-based procedures